Molecular Isoform Distribution and Glycosylation of Acetylcholinesterase Are Altered in Brain and Cerebrospinal Fluid of Patients with Alzheimer’s Disease

Abstract: The glycosylation of acetylcholinesterase (AChE) in CSF was analyzed by lectin binding. AChE from Alzheimer’s disease (AD) patients was found to bind differently to two lectins, concanavalin A and wheat germ agglutinin, than AChE from controls. As multiple isoforms of AChE are present in both CSF and brain, we examined whether the abnormal glycosylation of AD AChE was due to changes in a specific molecular isoform. Globular amphiphilic dimeric (G2a) and monomeric (G1a) isoforms of AChE were found to be differentially glycosylated in AD CSF. Glycosylation of AChE was also altered in AD frontal cortex but not in cerebellum and was also associated with an increase in the proportion of light (G2 and G1) isoforms. This study demonstrates that the glycosylation of AChE is altered in the AD brain and that changes in AChE glycosylation in AD CSF may reflect changes in the distribution of brain isoforms. The study also suggests that glycosylation of AChE may be a useful diagnostic marker for AD.

[1]  B. Thies,et al.  Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer's disease. , 1999 .

[2]  C. Masters,et al.  Acetylcholinesterase Is Increased in the Brains of Transgenic Mice Expressing the C‐Terminal Fragment (CT100) of the β‐Amyloid Protein Precursor of Alzheimer's Disease , 1998, Journal of neurochemistry.

[3]  D. Kaufer,et al.  Acute stress facilitates long-lasting changes in cholinergic gene expression , 1998, Nature.

[4]  Giovanni B. Frisoni,et al.  Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' , 1998 .

[5]  Nancy Reagan,et al.  Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease" , 1998 .

[6]  Y. Ashani,et al.  Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. , 1998, Molecular pharmacology.

[7]  B. Shaanan,et al.  Lectin-carbohydrate interactions: different folds, common recognition principles. , 1997, Trends in biochemical sciences.

[8]  M. Mesulam,et al.  Butyrylcholinesterase in the life cycle of amyloid plaques , 1997, Annals of neurology.

[9]  Z. Shen.  An CSF anomalous molecular form of acetylcholinesterase in demented and non‐demented subjects , 1997, Neuroreport.

[10]  C. Masters,et al.  Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease , 1997, The Lancet.

[11]  C. Masters,et al.  The Amyloid β‐Protein of Alzheimer's Disease Increases Acetylcholinesterase Expression by Increasing Intracellular Calcium in Embryonal Carcinoma P19 Cells , 1997, Journal of neurochemistry.

[12]  Y. Ashani,et al.  Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase. , 1997, Biochemistry.

[13]  N. Inestrosa,et al.  Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments. , 1996, Molecular psychiatry.

[14]  D. Small,et al.  Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease , 1996, Neurochemistry International.

[15]  P. Layer.  Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease , 1996, Neurochemistry International.

[16]  Claudia Linker,et al.  Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme , 1996, Neuron.

[17]  C. J. Vidal,et al.  Molecular forms of acetyl‐ and butyrylcholinesterase in normal and dystrophic mouse brain , 1996, Journal of neuroscience research.

[18]  D. Mann,et al.  Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer’s disease: an immunohistochemical study using end-specific Aβ monoclonal antibodies , 1996, Acta Neuropathologica.

[19]  R. Wolfert,et al.  Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .

[20]  H. Soreq,et al.  Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3'-terminal exons , 1995, Molecular and cellular biology.

[21]  S. Brimijoin,et al.  Regional variation in expression of acetylcholinesterase mRNA in adult rat brain analyzed by in situ hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Taylor,et al.  Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes. , 1994, The Journal of biological chemistry.

[23]  B. Crain,et al.  Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Journal of neuropathology and experimental neurology.

[24]  J. Palacios,et al.  Expression of acetylcholinesterase messenger RNA in human brain: Anin situ hybridization study , 1993, Neuroscience.

[25]  C. Geula,et al.  Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles, and patterns of selective vulnerability , 1993, Annals of neurology.

[26]  E. Muñoz-Delgado,et al.  Amphiphilic and hydrophilic forms of acetyl‐ and butyrylcholinesterase in human brain , 1993, Journal of neuroscience research.

[27]  Zhou Zhang,et al.  Anomalous acetylcholinesterase in CSF without clinical diagnosis of Alzheimer's disease , 1993, The Lancet.

[28]  F. Vallette,et al.  Molecular and cellular biology of cholinesterases , 1993, Progress in Neurobiology.

[29]  D. Small,et al.  A protease is recovered with a dimeric form of acetylcholinesterase in fetal bovine serum , 1993, Brain Research.

[30]  R. Zweig,et al.  Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer's disease , 1992, Neurobiology of Aging.

[31]  T. Arendt,et al.  Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development—A study of molecular forms , 1992, Neurochemistry International.

[32]  G. Turner.  N-glycosylation of serum proteins in disease and its investigation using lectins. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[33]  P. Layer,et al.  Butyrylcholinesterase from Chicken Brain Is Smaller than That from Serum: Its Purification, Glycosylation, and Membrane Association , 1992, Journal of neurochemistry.

[34]  H. Heider,et al.  Different Glycosylation in Acetylcholinesterases from Mammalian Brain and Erythrocytes , 1992, Journal of neurochemistry.

[35]  M. Esiri,et al.  Anomalous acetylcholinesterase in lumbar CSF in Alzheimer's disease , 1991, The Lancet.

[36]  J. Ulrich,et al.  Alzheimer's Disease: A Description of the Structural Lesions , 1991, Brain pathology.

[37]  A. Smith,et al.  Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease , 1991, The Lancet.

[38]  C. Geula,et al.  Immunocytochemical demonstration of axonal and perikaryal acetylcholinesterase in human cerebral cortex , 1991, Brain Research.

[39]  A. Gnatt,et al.  Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Marquis,et al.  Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain , 1990, Biological Psychiatry.

[41]  C. Geula,et al.  Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease , 1989, Brain Research.

[42]  J. Kaye,et al.  Cerebrospinal fluid cholinesterases in aging and in dementia of the alzheimer type , 1988, Annals of neurology.

[43]  C. Geula,et al.  Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles , 1987, Annals of neurology.

[44]  E. Kokmen,et al.  Alzheimer's disease and other dementing illnesses in a defined united states population: Incidence rates and clinical features , 1987, Annals of neurology.

[45]  E. Perry,et al.  Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in Human Plasma and Cerebrospinal Fluid , 1987, Journal of neurochemistry.

[46]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[47]  A. Afifi,et al.  Prevalence of Alzheimer's disease in a retirement community. , 1987, American journal of epidemiology.

[48]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[49]  S. Younkin,et al.  Molecular forms of acetylcholinesterases in Alzheimer's disease. , 1986, Federation proceedings.

[50]  E. Perry,et al.  Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System , 1986, Journal of neurochemistry.

[51]  S. Younkin,et al.  MOLECULAR FORMS OF ACETYLCHOLINESTERASE IN ALZHEIMERʼS DISEASE , 1986 .

[52]  E. Bird,et al.  Distribution of the molecular forms of acetylcholinesterase in human brain: Alterations in dementia of the Alzheimer type , 1986, Annals of neurology.

[53]  N. Sharon,et al.  Lectins as molecules and as tools. , 1986, Annual review of biochemistry.

[54]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[55]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Bernard,et al.  Interactions with lectins indicate differences in the carbohydrate composition of the membrane-bound enzymes acetylcholinesterase and 5'-nucleotidase in different cell types. , 1984, Biochimie.

[57]  F. Eckenstein,et al.  Identification of central cholinergic neurons containing both choline acetyltransferase and acetylcholinesterase and of central neurons containing only acetylcholinesterase , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  Robert H. Perry,et al.  Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form , 1983, Neuroscience Letters.

[59]  G. K. Wilcock,et al.  DECREASED CSF ACETYLCHOLINESTERASE ACTIVITY IN ALZHEIMER'S DISEASE , 1983, The Lancet.

[60]  J. Grassi,et al.  Molecular Forms of Acetylcholinesterase in Bovine Caudate Nucleus and Superior Cervical Ganglion: Solubility Properties and Hydrophobic Character , 1982, Journal of neurochemistry.

[61]  J. Massoulie,et al.  The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. , 1982, Annual review of neuroscience.

[62]  I. Silman,et al.  Intrinsic forms of acetylcholinesterase in skeletal muscle , 1978, FEBS letters.

[63]  R. Friede.  Enzyme Histochemical Studies of Senile Plaques , 1965 .

[64]  G B KOELLE,et al.  A Histochemical Method for Localizing Cholinesterase Activity.* , 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.